MHRA Webinar on International Recognition
The new international recognition procedure goes live from 1 January 2024, sitting alongside the MHRA’s current national procedures.
International recognition will support patients in the UK with expedited access to safe and effective medicines that have been approved by trusted regulatory partners by utilising pre-existing approvals from Australia, Canada, the European Union, Japan, Switzerland, Singapore and the United States.
We have published guidance on the International Recognition procedure as well as a recording of the first webinar.
This webinar will provide the latest information about the new route. This will include how to access and use the eligibility form and what to include in the eCTD submission. Potential applicants will be given the opportunity to ask questions.